Skip to content

13F-HR filed by Velan Capital Investment Management LP

Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 24 holding rows worth $100,819,000.

Accession
0001848809-22-000008
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 24 entries on the cover page, a total value of $100,819,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $100,819,000 with VALUE read as thousands by filing date, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR INDEX SHS FDS78463X202EURO STOXX 50500,000$15,380,000thousands by filing dateput
LANTHEUS HLDGS INC516544103COM200,000$14,066,000thousands by filing date
IMMUNOCORE HLDGS PLC ADS45258D105ADR293,385$13,771,000thousands by filing date
ADMA BIOLOGICS INC000899104COM5,269,155$12,804,000thousands by filing date
OPTINOSE INC68404V100COM2,176,572$7,966,000thousands by filing date
TELA BIO INC872381108COM746,087$6,357,000thousands by filing date
HEALTHCARE SVCS GROUP INC421906108COM400,000$4,836,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS68,829$4,260,000thousands by filing date
QUIPT HOME MEDICAL CORP74880P104COM800,000$3,336,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock225,000$2,835,000thousands by filing date
STARLING ONCOLOGY INC68236X100COMMON STOCK548,841$2,541,000thousands by filing date
JASPER THERAPEUTICS INC471871103COM3,219,036$2,240,000thousands by filing date
ZYMEWORKS INC98985W102COM234,902$1,445,000thousands by filing date
SONIDA SENIOR LIVING INC140475203COMMON STOCK82,832$1,345,000thousands by filing date
ALIMERA SCIENCES INC016259202COM227,602$1,156,000thousands by filing date
REZOLUTE INC76200L309COMMON STOCK400,000$1,096,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM100,000$1,056,000thousands by filing date
CONFORMIS INC20717E101COM5,156,406$986,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock20,000$722,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM39,957$640,000thousands by filing date
LUMIRADX LTDG5709L109SHS571,428$583,000thousands by filing date
ASSERTIO HOLDINGS INC04546C205COM NEW234,766$533,000thousands by filing date
NYXOAH S AB6S7WD106SHS79,021$498,000thousands by filing date
GLAUKOS CORP COM377322102Stock6,896$367,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001848809-22-000008this filing2022-11-14acceptance time not in the bulk data set